Stealth Robot-Maker Auris Buys Hansen For $80m
This article was originally published in Clinica
Auris Surgical Robotics, a private Silicon Valley start-up led by former Hansen Medical CEO and co-founder Frederic Moll, has agreed to buy Hansen for about $80m.
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
In this week’s podcast, Marion Webb reviews her interview with Glooko CEO Russ Johannesson and Reed Miller explains how Boston Scientific is restructuring its transcatheter aortic valve business.